1. Risk of health status worsening in primary infertile men: A prospective 10‐year follow‐up study
- Author
-
Eugenio Ventimiglia, Luca Boeri, Paolo Capogrosso, Filippo Pederzoli, Andrea Baudo, Giuseppe Fallara, Edoardo Pozzi, Francesco Montorsi, Federico Belladelli, Andrea Salonia, Nicola Frego, Massimo Alfano, Walter Cazzaniga, Boeri, L., Ventimiglia, E., Cazzaniga, W., Pederzoli, F., Fallara, G., Pozzi, E., Belladelli, F., Baudo, A., Frego, N., Capogrosso, P., Alfano, M., Montorsi, F., and Salonia, A.
- Subjects
Adult ,Male ,Infertility ,medicine.medical_specialty ,Time Factors ,Health Status ,Urology ,Endocrinology, Diabetes and Metabolism ,Comorbidity ,comorbidities ,Male infertility ,Endocrinology ,male ,spermatozoa ,Interquartile range ,health services administration ,Internal medicine ,follow-up ,medicine ,Humans ,Prospective Studies ,Risk factor ,Infertility, Male ,Proportional Hazards Models ,business.industry ,Proportional hazards model ,Hazard ratio ,Patient Acuity ,health ,Middle Aged ,medicine.disease ,Confidence interval ,risk factor ,Reproductive Medicine ,Disease Progression ,infertility ,business ,Body mass index ,Follow-Up Studies - Abstract
Background: A severe male infertility factor has been associated with both lower health status and increased mortality in infertile men. Objectives: To investigate reproductive factors associated with health status impairment in infertile men over a 10-year time frame since the first clinical evaluation. Materials and methods: Data from 899 infertile men were analysed at baseline between 2003 and 2010. Health-significant comorbidities were scored with the Charlson Comorbidity Index. Patients were followed up yearly recording any worsening in their health status until 2019. Cox regression models were used to estimate hazard ratios and 95% confidence intervals of Charlson Comorbidity Index score increase. Results: At a median follow-up of 136 months (Interquartile range: 121, 156), 85 men (9.5%) depicted an increase of their baseline Charlson Comorbidity Index score of at least one point. The most frequent reason for Charlson Comorbidity Index upgrade was cancer (34%), cardiovascular diseases (29%) and diabetes mellitus (22%). Compared to patients without a Charlson Comorbidity Index increase, patients with a Charlson Comorbidity Index increase presented with higher body mass index and follicle-stimulating hormone values, a higher rate of baseline Charlson Comorbidity Index ≥ 1 (all p 
- Published
- 2021
- Full Text
- View/download PDF